These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 1164014)

  • 1. Reduction of endotoxin levels in influenza virus vaccines by barium sulfate adsorption-elution.
    Reichelderfer PS; Manischewitz JF; Wells MA; Hochstein HD; Ennis FA
    Appl Microbiol; 1975 Aug; 30(2):333-4. PubMed ID: 1164014
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunogenicity of inactivated influenza vaccine, purified by adsorption chromatography on porous glas.
    Bresler S; Kolikov V; Katushkina N; Molodkin V; Friedman E; Zheleznova H; Malafeieva L; Peradze T; Beljakov V; Ivanov K
    Med Biol; 1975 Dec; 53(6):456-61. PubMed ID: 1214539
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Purification of large quantities of influenza virus by density gradient centrifugation.
    Reimer CB; Baker RS; Van Frank RM; Newlin TE; Cline GB; Anderson NG
    J Virol; 1967 Dec; 1(6):1207-16. PubMed ID: 5621490
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Host antigens in purified preparations of the influenza virus].
    Zhebrun AB; Polianskaia NIu; Noskov FS; Fridman EA
    Tr Inst Im Pastera; 1982; 59():70-81. PubMed ID: 7187572
    [No Abstract]   [Full Text] [Related]  

  • 5. A new, surface-antigen-adsorbed influenza virus vaccine. I. Studies on immunogenicity in hamsters.
    Jennings R; Potter CW; McLaren C; Brady M
    J Hyg (Lond); 1975 Dec; 75(3):341-52. PubMed ID: 1059704
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endotoxin content and clinical reactivity to influenza vaccines.
    Ennis FA; Dowdle WR; Barry DW; Hochstein HD; Wright PF; Karzon DT; Marine WM; Meyer HM
    J Biol Stand; 1977; 5(3):165-72. PubMed ID: 893462
    [No Abstract]   [Full Text] [Related]  

  • 7. Influenza vaccines: challenges and solutions.
    Houser K; Subbarao K
    Cell Host Microbe; 2015 Mar; 17(3):295-300. PubMed ID: 25766291
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Influenza virus vaccines].
    Schell KR
    Schweiz Med Wochenschr; 1980 Apr; 110(14):510-22. PubMed ID: 6154970
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Endotoxic contamination of biological products (ribosomal vaccines, viral vaccines and interferon)].
    Fumarola D; Panaro A; Palma R; Mazzone A
    G Batteriol Virol Immunol; 1979; 72(1-6):72-7. PubMed ID: 95449
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bacteriophages and endotoxin in licensed live-virus vaccines.
    Moody EE; Trousdale MD; Jorgensen JH; Shelokov A
    J Infect Dis; 1975 May; 131(5):588-91. PubMed ID: 805187
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The protection of ferrets against influenza by immunization with a split influenza vaccine.
    Brady MI; Furminger IG
    Dev Biol Stand; 1975; 28():167-72. PubMed ID: 1126566
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Analysis of the immunochemical purity of modern influenza vaccines].
    Zhebrun AB; Polianskaia NIu; Bichurina MA; Rozaeva NR; Fridman EA
    Zh Mikrobiol Epidemiol Immunobiol; 1986 Oct; (10):56-9. PubMed ID: 3799103
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A surface antigen influenza vaccine. 1. Purification of haemagglutinin and neuraminidase proteins.
    Brady MI; Furminger IG
    J Hyg (Lond); 1976 Oct; 77(2):161-72. PubMed ID: 1068195
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influenza: Can we cope better with the unpredictable?
    Dos Santos G; Neumeier E; Bekkat-Berkani R
    Hum Vaccin Immunother; 2016 Mar; 12(3):699-708. PubMed ID: 26360135
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Statistical determination of endotoxin content in influenza virus vaccine by the limulus amoebocyte lysate test.
    Rastogi SC; Hochstein HD; Seligmann EB
    J Clin Microbiol; 1977 Aug; 6(2):144-8. PubMed ID: 893659
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The human cell line PER.C6 provides a new manufacturing system for the production of influenza vaccines.
    Pau MG; Ophorst C; Koldijk MH; Schouten G; Mehtali M; Uytdehaag F
    Vaccine; 2001 Mar; 19(17-19):2716-21. PubMed ID: 11257414
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Methods of isolating the hemagglutinin of the influenza virus (a review)].
    Negrianu GM
    Tr Inst Im Pastera; 1982; 59():98-105. PubMed ID: 6764989
    [No Abstract]   [Full Text] [Related]  

  • 18. [On the adsorption of influenza and mumps virus and of endotoxin from S. abortus equi in human erythrocytes].
    FRITZE E; WORATZ H
    Z Immun exp ther; 1959; 118():368-83. PubMed ID: 13825292
    [No Abstract]   [Full Text] [Related]  

  • 19. Influenza viral neuraminidase: the forgotten antigen.
    Johansson BE; Cox MM
    Expert Rev Vaccines; 2011 Dec; 10(12):1683-95. PubMed ID: 22085172
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The search for the ideal influenza vaccine.
    Davenport FM
    Postgrad Med J; 1979 Feb; 55(640):78-86. PubMed ID: 461277
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.